56 related articles for article (PubMed ID: 34256714)
1. The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database.
Shen H; Deng G; Chen Q; Qian J
BMC Cancer; 2021 Jul; 21(1):825. PubMed ID: 34271858
[TBL] [Abstract][Full Text] [Related]
2. Classification of adenocarcinoma of the oesophagogastric junction.
Siewert JR; Stein HJ
Br J Surg; 1998 Nov; 85(11):1457-9. PubMed ID: 9823902
[No Abstract] [Full Text] [Related]
3. The development and validation of automated machine learning models for predicting lymph node metastasis in Siewert type II T1 adenocarcinoma of the esophagogastric junction.
Lu C; Liu L; Yin M; Lin J; Zhu S; Gao J; Qu S; Xu G; Liu L; Zhu J; Xu C
Front Med (Lausanne); 2024; 11():1266278. PubMed ID: 38633305
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
Stein HJ; von Rahden BH; Höfler H; Siewert JR
Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
[TBL] [Abstract][Full Text] [Related]
5. Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review.
Cao F; Hu C; Xu ZY; Zhang YQ; Huang L; Chen JH; Qin JJ; Cheng XD
Ann Transl Med; 2022 Mar; 10(6):377. PubMed ID: 35433931
[TBL] [Abstract][Full Text] [Related]
6. A novel risk score system for prognostic evaluation in adenocarcinoma of the oesophagogastric junction: a large population study from the SEER database and our center.
Wang J; Shi L; Chen J; Wang B; Qi J; Chen G; Kang M; Zhang H; Jin X; Huang Y; Zhao Z; Chen J; Song B; Chen J
BMC Cancer; 2021 Jul; 21(1):806. PubMed ID: 34256714
[TBL] [Abstract][Full Text] [Related]
7. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study.
Wang S; Chen L; Chen D; Chao J; Shao Y; Tang K; Chen W
Cancer Control; 2021; 28():10732748211066309. PubMed ID: 34910613
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.
Wang T; Wu Y; Zhou H; Wu C; Zhang X; Chen Y; Zhao D
BMC Gastroenterol; 2021 Jan; 21(1):38. PubMed ID: 33499821
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
Chen Y; Jin M; Shao Y; Xu G
Dis Markers; 2019; 2019():4659048. PubMed ID: 31781301
[TBL] [Abstract][Full Text] [Related]
11. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
12. Risk Assessment of Visceral Sarcomas: A Comparative Study of 2698 Cases from the SEER Database.
Dashti NK; Cates JMM
Ann Surg Oncol; 2021 Oct; 28(11):6852-6860. PubMed ID: 33538930
[TBL] [Abstract][Full Text] [Related]
13. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
14. The role of racial segregation in treatment and outcomes among patients with hepatocellular carcinoma.
Poulson MR; Blanco BA; Geary AD; Kenzik KM; McAneny DB; Tseng JF; Sachs TE
HPB (Oxford); 2021 Jun; 23(6):854-860. PubMed ID: 33536151
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study.
Wang R; Xie G; Shang L; Qi C; Yang L; Huang L; Li D; Yang W
Future Oncol; 2021 Mar; 17(8):893-906. PubMed ID: 33533669
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]